{"disease":{"id":"nafld","name":"nafld"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"pf-05221304","indication_name":"Nonalcoholic fatty liver disease (NAFLD)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-05221304","generic_name":"pf-05221304","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Acetyl-CoA carboxylase (ACC1 and ACC2)","drug_class":"Acetyl-CoA carboxylase inhibitor","quality_score":27,"revenue":null,"mechanism":"Selective inhibitor of acetyl-CoA carboxylase (ACC1/ACC2) that reduces hepatic lipogenesis and promotes fatty acid oxidation."},{"drug_id":"pf-05221304","indication_name":"NAFLD/NASH (combination therapy with DGAT2i)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-05221304","generic_name":"pf-05221304","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Acetyl-CoA carboxylase (ACC1 and ACC2)","drug_class":"Acetyl-CoA carboxylase inhibitor","quality_score":27,"revenue":null,"mechanism":"Selective inhibitor of acetyl-CoA carboxylase (ACC1/ACC2) that reduces hepatic lipogenesis and promotes fatty acid oxidation."}],"offLabel":[],"totalMarketed":0,"totalPipeline":2},"trials":{"data":[{"nct_id":"NCT03534908","title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study","phase":"","overall_status":"UNKNOWN","enrollment_count":5000000,"lead_sponsor_name":"Wuhan University","has_results":false},{"nct_id":"NCT03151473","title":"Longitudinal Observational Study Of Chinese With NAFLD/NASH","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Humanity and Health Research Centre","has_results":false},{"nct_id":"NCT07241195","title":"A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"The Affiliated Hospital of Hangzhou Normal University","has_results":false},{"nct_id":"NCT04099147","title":"Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.","phase":"","overall_status":"UNKNOWN","enrollment_count":14046,"lead_sponsor_name":"Instituto de Investigación Marqués de Valdecilla","has_results":false},{"nct_id":"NCT05255978","title":"A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Qin Ning","has_results":false},{"nct_id":"NCT05857319","title":"Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Groupe Éthique et Santé","has_results":false},{"nct_id":"NCT04442334","title":"The European NAFLD Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Newcastle University","has_results":false},{"nct_id":"NCT03525769","title":"Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04371042","title":"PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07070362","title":"Digital Early Warning System for Acute Lung Injury in Liver Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT06566105","title":"The Liver BIoBank Lombardia of Fatty Liver","phase":"NA","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT06115876","title":"Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Dasman Diabetes Institute","has_results":false},{"nct_id":"NCT05699018","title":"Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":1788,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT05872269","title":"A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Zydus Lifesciences Limited","has_results":false},{"nct_id":"NCT04795219","title":"Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1250,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05554224","title":"Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1104,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT04681573","title":"Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD","phase":"NA","overall_status":"RECRUITING","enrollment_count":1045,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT03726827","title":"A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations","phase":"","overall_status":"COMPLETED","enrollment_count":1006,"lead_sponsor_name":"Fatty liver Foundation","has_results":false},{"nct_id":"NCT03695796","title":"French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1005,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT05971082","title":"Risk Factors for Advanced Fibrosis Among FLD Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Helsinki University Central Hospital","has_results":false},{"nct_id":"NCT03289897","title":"Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan","phase":"NA","overall_status":"COMPLETED","enrollment_count":801,"lead_sponsor_name":"Perspectum","has_results":false},{"nct_id":"NCT04220450","title":"T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Dr. Andreas Kammerlander","has_results":false},{"nct_id":"NCT04232293","title":"Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus","phase":"NA","overall_status":"COMPLETED","enrollment_count":722,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04664036","title":"Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT06315361","title":"DIAbetes and NAFLD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06688149","title":"NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":536,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT04653103","title":"NASH in Subjects With Different Classes of Obesity","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Catholic University of the Sacred Heart","has_results":false},{"nct_id":"NCT06098417","title":"Biomarkers in the Diagnosis and Prognosis of NAFLD","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Trieste","has_results":false},{"nct_id":"NCT06503068","title":"Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT05479721","title":"LITMUS Imaging Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05370053","title":"The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology","phase":"NA","overall_status":"UNKNOWN","enrollment_count":450,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false},{"nct_id":"NCT06888310","title":"Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":408,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06348563","title":"AGED Diagnostics Liver Disease Assessment","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Active Genomes Expressed Diagnostics, Corp","has_results":false},{"nct_id":"NCT04215926","title":"NAFLD in HIV-infected Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Shanghai Public Health Clinical Center","has_results":false},{"nct_id":"NCT07180745","title":"Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Badr University","has_results":false},{"nct_id":"NCT05023044","title":"Nonalcoholic Fatty Liver Disease in HIV Database","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06445335","title":"Prevalence of NAFLD in T2DM Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":385,"lead_sponsor_name":"Ziekenhuis Oost-Limburg","has_results":false},{"nct_id":"NCT05877547","title":"A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05051527","title":"Study to Evaluate the Effectiveness of Legalon®","phase":"","overall_status":"COMPLETED","enrollment_count":362,"lead_sponsor_name":"Mylan Inc.","has_results":false},{"nct_id":"NCT05647915","title":"Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":337,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT04366999","title":"Effectiveness of Bariatric Surgery for NAFLD/NASH","phase":"","overall_status":"RECRUITING","enrollment_count":320,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT03864510","title":"NAFLD in Diabetes Type 2 in Primary Care","phase":"","overall_status":"COMPLETED","enrollment_count":317,"lead_sponsor_name":"Linkoeping University","has_results":false},{"nct_id":"NCT05499949","title":"The Franciscus Obesity NASH Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Franciscus Gasthuis","has_results":false},{"nct_id":"NCT06220695","title":"A Nutrigenetic Intervention in MASLD","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Maastricht University","has_results":false},{"nct_id":"NCT04774302","title":"Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD","phase":"","overall_status":"COMPLETED","enrollment_count":292,"lead_sponsor_name":"Clinique Pasteur","has_results":false},{"nct_id":"NCT04146636","title":"Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study)","phase":"NA","overall_status":"COMPLETED","enrollment_count":282,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT06332677","title":"Target of Suv420h1/2 in Hepatocytes","phase":"NA","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT04634643","title":"Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)","phase":"","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT04812262","title":"A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":255,"lead_sponsor_name":"Neuraly, Inc.","has_results":false},{"nct_id":"NCT06879236","title":"Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":252,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}